Science Angel Syndicate backed the funding round alongside a broad group of institutional and angel investors.
MitoRx Therapeutics
Developing targeted therapeutics to arrest the progression of degenerative diseases.
MitoRx Therapeutics develops targeted therapeutics designed to address mitochondrial dysfunction and halt the progression of degenerative diseases.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from MitoRx Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
MW
Matt Whiteman
Academic Founder and CSO